Al-Mashhadi, Z.
Viggers, R.
Fuglsang-Nielsen, R.
de Vries, F.
van den Bergh, J. P.
Harsløf, T.
Langdahl, B.
Gregersen, S.
Starup-Linde, Jakob http://orcid.org/0000-0002-4325-8023
Funding for this research was provided by:
Novo Nordisk Fonden (NNF18OC0052064)
Article History
Accepted: 24 October 2020
First Online: 9 November 2020
Compliance with Ethical Standards
: Zheer Al-Mashhadi and Jakob Starup-Linde drafted the manuscript, conducted the systematic literature search contributed to the interpretation of data, critical editing of written text, and approved the final version of the manuscript. Rikke Viggers, Rasmus Fuglsang-Nielsen, Frank de Vries, Joop van den Bergh, Torben Harsløf, Bente Langdahl, and Søren Gregersen contributed to the interpretation of data, critical editing of written text, and approved the final version of the manuscript.
: Z Al-Mashhadi, R Viggers, R Fuglsang-Nielsen, JP van den Bergh, T Harsløf and S Gregersen declare no conflict of interest.J. Starup-Linde reports personal fees from GSK Pharma A/S and Gilead Sciences Denmark, outside the submitted work.F. de Vries supervises three PhD students who are currently employed with F. Hoffmann La Roche Ltd. (Welwyn Garden City UK and Basel, Switzerland). The topics of their PhDs do not relate to the current study. Dr. de Vries has not received any fees or reimbursements for this.JP van den Bergh reports grants from Amgen, UCB and Eli-Lilly and personal fees from UCB and Amgen outside the submitted work.B. Langdahl reports grants from Amgen, grants from Novo Nordisk, personal fees from Amgen, personal fees from UCB, personal fees from Gedeon-Richter, personal fees from Gilead, outside the submitted work.
: This article does not contain any studies with human or animal subjects performed by any of the authors.